Muscarinic M3 receptor and beta-3 adrenergic receptor — Drug Target

All drugs that target Muscarinic M3 receptor and beta-3 adrenergic receptor — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Antimuscarinic and beta-3 adrenergic agonist combination

Marketed (1)

• tolterodine , mirabegron · Far Eastern Memorial Hospital · Antimuscarinic and beta-3 adrenergic agonist combination · Urology
  Tolterodine and mirabegron work together to reduce overactive bladder symptoms through complementary pathways: tolterodine blocks muscarinic receptors to decrease bladder contractions, while mirabegron activates beta-3 adrenergic receptors to relax the detrusor muscle.